ALLO-ASC-DFU: Clinical Trials

15 trials of ALLO-ASC-DFU, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 1 recruiting. 4 Phase 2, 3 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 13Completed 3
Phase 32Completed 2

Follow ALLO-ASC-DFU: new trials by email Literature Review of ALLO-ASC-DFU trials Research Report on ALLO-ASC-DFU

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial
ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer
RecruitingAnterogen Co., Ltd.1042023-04-252024-12-13
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers.
ALLO-ASC-DFU, Vehicle Sheet - Diabetic Foot Ulcer
Phase 3CompletedAnterogen Co., Ltd.1042020-07-142025-09-22
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial
ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer
CompletedAnterogen Co., Ltd.732020-06-242023-08-25
Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers
ALLO-ASC-DFU, Hydrogel SHEET(Vehicle control) - Diabetic Foot Ulcer
Phase 2CompletedAnterogen Co., Ltd.662019-01-022025-01-23
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers.
ALLO-ASC-DFU, Vehicle sheet - Diabetic Foot Ulcer
Phase 3CompletedAnterogen Co., Ltd.1502018-06-272023-08-25
A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial
ALLO-ASC-DFU - Dystrophic Epidermolysis Bullosa
CompletedAnterogen Co., Ltd.22017-12-082023-08-25
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-201 Clinical Trial
ALLO-ASC-DFU - Burn
CompletedAnterogen Co., Ltd.142016-08-292023-08-25
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-101 Clinical Trial
ALLO-ASC-DFU - Diabetic Foot Ulcer
CompletedAnterogen Co., Ltd.42016-01-112018-01-10
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-201 Clinical Trial
ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer
CompletedAnterogen Co., Ltd.542015-12-292023-08-25
A Clinical Trial to Evaluate the Safety and Efficacy of ALLO-ASC-DFU for Second Deep Degree Burn Injury Subjects
ALLO-ASC-DFU, Conventional Therapy - Burn Injury
Phase 2CompletedAnterogen Co., Ltd.202015-12-232023-08-25
Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa
Allogeneic mesenchymal stem cells, Polyurethene Film - Dystrophic Epidermolysis Bullosa
Phase 1 / Phase 2CompletedAnterogen Co., Ltd.22015-12-082023-08-25
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial
ALLO-ASC-DFU - Burn
CompletedAnterogen Co., Ltd.52015-11-012018-01-10
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers
ALLO-ASC-DFU, Standard therapy - Diabetic Foot Ulcer
Phase 2CompletedAnterogen Co., Ltd.592015-10-012017-09-01
A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound
ALLO-ASC-DFU - Burn
Phase 1CompletedAnterogen Co., Ltd.52015-03-012015-12-30
Safety of ALLO-ASC-DFU in the Patients With Diabetic Foot Ulcers
ALLO-ASC-DFU - Diabetic Foot Ulcer
Phase 1CompletedAnterogen Co., Ltd.52014-11-012015-10-16

Conditions studied

Diabetic Foot (9)  ·  Burns (4)  ·  Epidermolysis Bullosa (2)  ·  Epidermolysis Bullosa Dystrophica (2)

Sponsors

Anterogen Co., Ltd. (15)

Countries

South Korea (13)  ·  United States (1)

Top investigators

JiUng Bak, MD. Ph D (2)  ·  Ki-Won Young, MD. Ph D. (2)  ·  Seung-Kyu Han, MD. Ph D. (2)  ·  Wook Chun, MD, PhD (2)  ·  Wook Chun, PhD (2)  ·  Alexander M. Reyzelman, DPM (1)  ·  BaekKyu Kim, MD. Ph D (1)  ·  Chan Kang, MD. Ph D. (1)  ·  ChanYeong Heo, MD. Ph D. (1)  ·  ChangSik Park, MD. Ph D (1)  ·  Changsik Park, MD. Ph D. (1)  ·  DaeWon Jun, MD. Ph D (1)  ·  David G. Armstrong, MD.Ph D. (1)  ·  Donghyeok Shin, MD. Ph D. (1)  ·  Hyun-suk Suh, MD, PhD (1)

Results publications

PMID 30679183